| Application no. and date | 21707690.0 (espacenet) (Federated) (European Patent Register), 20210226 | | Patent/reg. no. and date | DK/EP 4110326, 20240131 | | Publication date | 20230104 | | Priority no. and date | EP 20305190, 20200227 | | EP pub. no. and date |
EP 4110326 20230104 | | Effective date | | | Applicant/owner | SANOFI, 46 avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | | | Inventor | BOUABOULA, Monsif, c/o Sanofi 55 Corporate Drive
BRIDGEWATER, NJ 08807, US,
GUO, Zhuyan, c/o Sanofi 55 Corporate Drive
BRIDGEWATER, NJ 08807, US,
POIRIER, Stéphane, c/o Sanofi 55 Corporate Drive
BRIDGEWATER, NJ 08807, US,
SHOMALI, Maysoun, c/o Sanofi 55 Corporate Drive
BRIDGEWATER, NJ 08807, US,
SUN, Fangxian, c/o Sanofi 55 Corporate Drive
BRIDGEWATER, NJ 08807, US | | Representative | | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | COMBINATION COMPRISING ALPELISIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID | | Int. application no. | EP2021054815 | | Int. publication no. | WO2021170793 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
